Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
AXSM
Stock Latest News
The Fly
Biotech Alert: Searches spiking for these stocks today
18h ago
PTN
SNY
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2d ago
ALLR
ALNY
Premium
The Fly
Mizuho ups Axsome target, calls selloff on data ‘misplaced’
2d ago
AXSM
Premium
Ratings
Positive Outlook on Axsome Therapeutics Despite Modest Market Reaction
2d ago
AXSM
Premium
Ratings
Buy Rating Affirmed for Axsome Therapeutics Amid Promising ADHD Treatment Results and Strategic Market Positioning
3d ago
AXSM
Premium
The Fly
Axsome Therapeutics announces FOCUS Phase 3 trial achieved primary endpoint
4d ago
AXSM
Premium
Ratings
Axsome Therapeutics’ Promising Phase III FOCUS Trial Results Boost Buy Rating
4d ago
AXSM
Premium
Ratings
Positive Phase 3 Trial Results for Axsome Therapeutics’ Solriamfetol Drive Buy Rating Amid Market Uncertainties
4d ago
AXSM
Premium
Ratings
Strong Growth and Positive Outlook for Axsome Therapeutics’ Auvelity Drives Buy Rating
4d ago
AXSM
Premium
Ratings
Strong Market Performance and Growth Potential of Auvelity Drives Positive Outlook for Axsome Therapeutics
6d ago
AXSM
Premium
Ratings
Axsome Therapeutics’ AXS-12: A Promising Asset in Narcolepsy Treatment Driving Buy Rating
11d ago
AXSM
Premium
The Fly
Axsome Therapeutics management to meet with Truist
11d ago
AXSM
Premium
Ratings
Axsome Therapeutics: Strong Performance and Untapped Potential in Sunosi Drive Buy Rating
16d ago
AXSM
Premium
Ratings
Axsome Therapeutics: Strategic Developments and Market Exclusivity Drive Buy Rating
23d ago
AXSM
Premium
The Fly
Axsome Therapeutics management to meet with Piper Sandler
24d ago
AXSM
Premium
The Fly
Axsome Therapeutics settles Sunosi patent litigation with Hikma
24d ago
AXSM
Premium
Ratings
Positive Outlook for Axsome Therapeutics Amid sNDA Progress and Strategic Pricing
25d ago
AXSM
Premium
Ratings
Axsome Therapeutics: Promising Regulatory Progress and Market Potential Justify Buy Rating
25d ago
AXSM
Premium
Ratings
Axsome Therapeutics’ AXS-05: Promising Regulatory Progress and Strategic Positioning for Market Success
25d ago
AXSM
Premium
Ratings
Positive FDA Feedback and Strategic Moves Bolster Axsome Therapeutics’ Buy Rating
26d ago
AXSM
Premium
The Fly
Axsome Therapeutics expects to submit sNDA for AXS-05 in Q3
26d ago
AXSM
Premium
The Fly
Axsome Therapeutics price target raised to $160 from $132 at Baird
26d ago
AXSM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
